Abstract 1733: XL495 is a potent, selective, and orally bioavailable inhibitor of PKMYT1

Authors: Dana Gwinn, Jimmy Lai, Alice Rico, Christopher Kochansky, Nina M. Muñoz, Ragadeepthi Tunduguru, Aditya Kumar, Pragalath Sundararajan, Akhil Choppa, Donna Fong, Mi Chen, Amy Hildebrand, Jeremy Murray, Christopher Szeto, Matthew G. Rees, Melissa M. Ronan, Jennifer A. Roth, Wei Xu, Paul Gillespie, Paige Mahaney, Dana T. Aftab, Lisa D. Belmont, Jae H. Chang

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-1733

Source: Full article


Abstract

Background: